EMVision Reports Very Encouraging Pilot Clinical Trial Data

Submitted by admin on Thu, 10/29/2020 - 13:56
EMVision Fusion Images

A total of 30 patient datasets (21 ischaemic and 9 haemorrhagic) were processed for this primary study analysis. The primary end point was met, with significant data collected to inform the value proposition and guide improvements in device hardware and software. •It was observed that the EMVision device was able to classify stroke type (haemorrhagic or ischaemic) with an overall accuracy of between 93.3% and 96%. It was observed that the EMVision device was able to localize targets in the correct quadrant (compared to ground truth CT/MRI) with an overall accuracy of between 86.7% and 96%.